low financeVERIFIED
Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22%
🕐 9h ago·2 outlets
How sure are we
✓ Verified · 2 outlets
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
Verification Log1
cross checkconfirmed90%
[Claude] All three other reports cover the same Novo Nordisk 2026 forecast raise and its Q3 results, and none contradict Report 1's facts.
1h agoPowered by WorldPulse Verification Engine
Reliability
Reliability ScoreVery high
85%Independent outlets2
Statusverified
AI checknone yet
Community flags0
Score bands
Very high80–100%
A highly rated outlet, or several independent outletsHigh60–79%
One well-rated outlet so farModerate40–59%
A lower-rated or state-run outlet, or one report of something seriousLow20–39%
A low-rated outlet on a serious or sensitive storyVery low0–19%
Treat it as unconfirmedWhat moves the score
◎
Outlet ratingThe outlet’s rating in WorldPulse’s list of sources starts the score
⇄
Independent outletsEach further outlet that reports the story closes 40% of the gap to 98%
±
Report detailsA few points either way: a summary and a place add a little; state-run outlets on conflict, politics or security, and single reports marked high or critical, lose some
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this
Risk Score
low risk